Kernicterus Eye Signs (Sunset Eyes)

What is Kernicterus eye signs (sunset eyes)?

Kernicterus eye signs, commonly called sunset eyes, describe a characteristic upward‑gazing stare seen in newborns with severe hyperbilirubinemia (high levels of bilirubin in the blood). The eyes appear to be “looking toward the sunrise” because the lower eyelid margins are obscured by yellow‑colored sclera while the upper part of the eye remains visible. This sign reflects bilirubin toxicity affecting the brain stem, specifically the cranial nerve pathways that control eye movement, and is considered an early neurologic indicator of possible kernicterus.

Kernicterus itself is a rare but serious form of bilirubin‑induced brain damage that can lead to permanent neurological deficits, such as hearing loss, cerebral palsy, or intellectual disability. Detecting sunset eyes early can prompt urgent treatment and may prevent irreversible injury.

Sources: Mayo Clinic; American Academy of Pediatrics (AAP); National Institutes of Health (NIH)

Common Causes

While sunset eyes are most often a manifestation of severe neonatal jaundice, several underlying conditions can precipitate the bilirubin rise that produces this sign.

• Physiologic newborn jaundice – normal breakdown of fetal hemoglobin, usually resolves within the first week.
• Hemolytic disease of the newborn (HDN) – due to blood‑type incompatibility (ABO or Rh) or allo‑immune hemolysis.
• Breast‑feeding jaundice – inadequate milk intake leads to dehydration and reduced bilirubin excretion.
• Breast‑feeding jaundice (also called breastfeeding‑associated jaundice) – “milk‑of‑the‑day” delay in establishing adequate lactation.
• Genetic enzyme deficiencies – such as glucose‑6‑phosphate dehydrogenase (G6PD) deficiency or hereditary spherocytosis.
• Crigler‑Najjar syndrome type I – a rare autosomal‑recessive disorder with absent bilirubin‑UDP‑glucuronosyltransferase activity.
• Sepsis or severe infection – increases hemolysis and impairs hepatic conjugation.
• Prematurity – immature liver enzymes and blood‑brain barrier increase bilirubin toxicity risk.
• Metabolic disorders – e.g., hypothyroidism or inborn errors of metabolism that interfere with bilirubin clearance.
• Medications – certain antibiotics (e.g., sulfonamides) or drugs that displace bilirubin from albumin.

Associated Symptoms

Sunset eyes rarely occur in isolation. They are often accompanied by other signs of severe jaundice or neurologic compromise:

• Yellow skin and sclera (classic jaundice) that spreads from the head downwards.
• Lethargy or poor feeding – the infant may be difficult to awaken.
• High‑pitched cry or weak cry.
• Hypotonia (floppiness) or, conversely, hypertonia (stiffness) in limbs.
• Seizures – especially focal or generalized tonic‑clonic activity.
• Apnea or irregular breathing patterns.
• Auditory abnormalities – later developing hearing loss is a hallmark of kernicterus.
• Movement disorders – such as choreoathetoid movements (writhing motions).

When to See a Doctor

Newborn jaundice is common, but you should seek medical care immediately if you notice any of the following:

• Yellowing that spreads beyond the face to the chest, abdomen, or limbs.
• Dark yellow or brown‑ish urine and pale or clay‑colored stools.
• Any upward‑gazing stare, “sunset eyes,” or difficulty keeping the eyes open.
• Excessive sleepiness, difficulty waking for feeds, or poor weight gain.
• High‑pitched or absent crying, seizures, or abnormal movements.
• Feeding problems (refusal to breastfeed or poor suck).
• Signs of infection – fever, lethargy, vomiting, or a tender abdomen.

Because bilirubin can cross a newborn’s immature blood‑brain barrier quickly, early evaluation is crucial.

Diagnosis

Healthcare providers use a combination of visual assessment, laboratory testing, and sometimes imaging to confirm the cause and severity of sunset eyes.

1. Physical Examination

• Inspection of skin and scleral color.
• Assessment of eye position – looking upward (sunset) while the lower lid is obscured.
• Neurologic exam for tone, reflexes, and responsiveness.

2. Serum Bilirubin Measurement

A total serum bilirubin (TSB) level is drawn. Values above the age‑adjusted phototherapy threshold (often >12–15 mg/dL in term infants, lower in preterms) raise concern. Direct (conjugated) bilirubin is measured to rule out cholestatic disease.

3. Blood Type & Coombs Test

Determines maternal‑infant blood‑type incompatibility and immune‑mediated hemolysis.

4. Complete Blood Count (CBC) & Reticulocyte Count

Evaluates hemolysis and anemia.

5. Liver Function Tests (LFTs)

Assess hepatic injury or metabolic disease.

6. Screening for G6PD Deficiency

Especially in populations with higher prevalence (African, Mediterranean, Asian descent).

7. Neuroimaging (rare)

If neurologic sequelae are suspected, an MRI may show basal ganglia hyperintensity characteristic of kernicterus.

8. Auditory Brainstem Response (ABR) Testing

Baseline hearing evaluation, as hearing loss can develop later.

Treatment Options

Management aims to lower serum bilirubin quickly, prevent bilirubin from entering the brain, and treat the underlying cause.

1. Phototherapy

• Blue‑light (460–490 nm) converts bilirubin into water‑soluble isomers that can be excreted without conjugation.
• Intermittent or continuous exposure depending on bilirubin level and gestational age.
• Modern LED phototherapy pads are more efficient and cause less heat.

2. Exchange Transfusion

Indicated when bilirubin is critically high (often >20–25 mg/dL in term infants) or when phototherapy fails. Blood is removed and replaced with donor blood, rapidly reducing bilirubin and circulating antibodies.

3. Intravenous Immunoglobulin (IVIG)

Used for immune‑mediated hemolysis (e.g., ABO or Rh incompatibility) to decrease antibody‑mediated red‑cell destruction.

4. Adequate Feeding & Hydration

• Frequent breastfeeding (8–12 times/day) or supplemental formula to increase stool output and bilirubin excretion.
• If oral intake is insufficient, consider nasogastric feeds.

5. Address Underlying Causes

• Treat infection with appropriate antibiotics.
• For G6PD deficiency, avoid oxidative drugs and provide supportive care.
• In Crigler‑Najjar type I, liver transplantation may be definitive; until then, intensive phototherapy and possible liver‑directed gene therapy trials are options.

6. Home Care After Hospital Discharge

• Continue regular feeding.
• Monitor stool color (should be yellow/brown) and urine output.
• Schedule follow‑up bilirubin checks as directed.
• Keep infants out of direct sunlight (which can degrade bilirubin but also cause skin damage).

Prevention Tips

Many cases of severe jaundice are preventable with early detection and proper care.

• Early post‑natal visits – ensure newborns are examined within 24–48 hours after discharge.
• Frequent feeding – aim for 8–12 feeds per day for the first week.
• Monitor jaundice at home – use a jaundice assessment chart or transcutaneous bilirubinometer if available.
• Identify risk factors – prematurity, family history of hemolytic disease, or known enzyme deficiencies.
• Maternal blood‑type screening and administration of Rh immunoglobulin when indicated.
• Prompt treatment of infections in the newborn period.
• Avoid medications that displace bilirubin in infants, especially sulfonamides and some NSAIDs.
• Educate parents about the signs of worsening jaundice (e.g., “sunset eyes,” increasing lethargy).

Emergency Warning Signs

Key Take‑aways

• Sunset eyes are a neurologic warning sign of severe neonatal hyperbilirubinemia and possible kernicterus.
• Prompt recognition, measurement of serum bilirubin, and initiation of phototherapy can prevent permanent brain injury.
• Underlying causes range from physiologic jaundice to hemolytic disease, infections, and rare genetic disorders.
• Parents should monitor feeding, urine/stool output, and skin color closely during the first two weeks of life.
• Emergency medical evaluation is required for any upward‑gazing stare, worsening jaundice, or neurologic decline.

References:

• Mayo Clinic. Kernicterus. Accessed May 2024.
• American Academy of Pediatrics. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. 2022 guideline.
• National Institutes of Health (NIH). Neonatal Jaundice. Updated 2023.
• Centers for Disease Control and Prevention (CDC). Kernicterus and Neonatal Jaundice. 2023.
• Cleveland Clinic. Kernicterus. Reviewed 2022.